Apart from CD38, SARM1 were also confirmed as the additional NAD+-depleting enzyme that using NAD+ to produce cADPR, the precise functions of cADPR in those abnormal situations including tumor progression, inflammation, and injury-induced axon death need further characterizations [43, 44]. This evidence concerns the gene CD38 and neoplasm.